Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Clasp Therapeutics, Inc.

Clinical trials sponsored by Clasp Therapeutics, Inc., explained in plain language.

Trials to join now! 1

First-of-its-Kind cancer drug targets 'Guardian Gene' mutation

Disease control Recruiting now

This is a first-in-human study testing a new drug called CLSP-1025 for adults with advanced solid tumors that have a specific genetic change called the p53 R175H mutation. The main goals are to find a safe dose and see if the drug can help control the cancer. The drug works by en…

Phase: PHASE1 • Sponsor: Clasp Therapeutics, Inc. • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC